Table 3.1.
Results of the Analysis Using Tau‐U for Anxiety and Coping for the Participant
| Tau‐U | p‐Value | 90% CI | |
|---|---|---|---|
| Trend Estimates | |||
| Coping (EXP) | 0.065 | 0.64 | [−0.165, 0.294] |
| Coping (EXP+CT) | 0.534 | <0.01* | [0.330, 0.739] |
| Coping (FU) | −0.275 | 0.17 | [−0.605, 0.055] |
| Anxiety (EXP) | 0.009 | 0.95 | [−0.220, 0.239] |
| Anxiety (EXP+CT) | −0.280 | 0.02* | [−0.485, −0.076] |
| Anxiety (FU) | 0.407 | 0.04* | [0.076, 0.737] |
| Between‐Phase Level Difference | |||
| Coping (EXP vs. EXP+CT) | 0.718 | <0.01* | [0.465, 0.970] |
| Coping (EXP+CT vs. FU) | −0.092 | 0.62 | [−0.399, 0.216] |
| Anxiety (EXP vs. EXP+CT) | 0.160 | 0.30 | [−0.093, 0.413] |
| Anxiety (EXP+CT vs. FU) | −0.221 | 0.24 | [−0.529, 0.087] |
| Corr. Between‐Phase Level Difference | |||
| Coping (EXP+CT vs. FU) | −0.683 | <0.01* | [−0.991, −0.375] |
| Anxiety (EXP+CT vs. FU) | 0.089 | 0.63 | [−0.218, 0.397] |
Note. Obtained using the Tau‐U web‐based calculator (Vannest et al., 2016) * p <.05, EXP = exposure phase (B), EXP+CT = exposure + cognitive therapy phase (C), FU = follow‐up phase (D)